We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Henderson Mrly. | LSE:HML | London | Ordinary Share | GB0030711229 | ORD 0.125P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.085 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMHML RNS Number : 1629R Henderson Morley PLC 17 August 2010 17 August 2010 HENDERSON MORLEY PLC ("Henderson Morley" or the "Company") (AIM: HML) ADDITIONAL SECURED LOANS FROM DIRECTORS Henderson Morley plc, the Aim quoted biotechnology company, announces that further to the announcement dated 03 August 2010 regarding Director's loans, Andrew Knight and Dr Ian Pardoe have advanced a further GBP5,000 under the same terms. -END- Enquires: HENDERSON MORLEY PLC Andrew Knight, Chairman 0121 442 4600 Chris Pate, Independent Director 0121 444 5309 BREWIN DOLPHIN CORPORATE ADVISORY & BROKING Neil Baldwin 0845 213 4726 BISHOPSGATE COMMUNICATIONS LTD Maxine Barnes 0207 562 3350 Gemma O'Hara This information is provided by RNS The company news service from the London Stock Exchange END STREAXPKFLAEEFF
1 Year Henderson Mrly. Chart |
1 Month Henderson Mrly. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions